Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Patents
  • Published:

Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity

Nature Biotechnology volume 22, pages 1591–1592 (2004)Cite this article

Can Israel balance the rights of multinational drug companies with its own generic pharmaceutical industry?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Amendment to The Patents Law, 5727–1967 (1998 Amendment).

  2. See 35 USC 155, 155A, 156, 271(e); Proposed directive amending directive 2001/83/EC, Article 10.4.

  3. The Pharmacists Ordinance, New Version (1981). Laws of the state of Israel, State of Israel.

  4. US, Israeli officials to tackle dispute over drug data exclusivity. IP Law Bulletin (October 11, 2004).

  5. US, Israeli negotiators make progress in talks on drug IP rights. IP Law Bulletin (October 17, 2004).

  6. Intellectual property bill risks US censure. Jerusalem Post (September 9, 2004).

  7. Drugs vote Republican, which may be why the US is pressing Israel so hard on IP. Globes Online (September 26, 2004).

Download references

Author information

Authors and Affiliations

  1. Reinhold Cohn and Partners, PO Box 4060, Tel Aviv, 61040, Israel

    Tamar Morag-Sela & Ilan Cohn

  2. Merial Ltd.,, 3239 Satellite Blvd., Duluth, 30096-4640, Georgia, USA

    Judy Jarecki-Black

  3. D. Young & Co.,, 120 Holborn, London, EC1N 2DY, UK

    Zoe Clyde-Watson

Authors
  1. Tamar Morag-Sela
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilan Cohn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J Kowalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Judy Jarecki-Black
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zoe Clyde-Watson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morag-Sela, T., Cohn, I., Kowalski, T. et al. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity. Nat Biotechnol 22, 1591–1592 (2004). https://doi.org/10.1038/nbt1204-1591

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1204-1591

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing